FRT [MARKET PERFORM -1.8%] - Accelerated pharmacy expansion to weigh on profits - Update
  • 24 Feb 2020
  • Company Research
We maintain our MARKET PERFORM rating while cutting our target price by 25% due to downward revisions of 47%/65%/58% to our 2020F/2021F/2022F NPAT-MI as we revise down our forecasts for both the mobile (FPT Shop) and pharmacy (Long Chau/LC) businesses. FR